# $ctmx

CytomX Therapeutics is seeing significant social media buzz with engagements up 153.65% week-over-week, driven by discussions around Varseta-M for CRC and upcoming CX-801 Melanoma results, despite concerns about the CX-2051 Phase [--] update.

### About $ctmx
CytomX Therapeutics is a biopharmaceutical company focused on developing cancer therapies.  

### Insights
- $ctmx sentiment is up 33.33% from the previous week.
- $ctmx engagements is up 153.65% from the previous week.

### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ctmx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ctmx/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [-----] +154%  
[--] Month: [-------] +114%  
[--] Months: [---------] -22%  
[--] Year: [---------] +46%  
1-Year High: [-------] on 2025-06-05  
1-Year Low: [--] on 2025-04-19  

Engagements by network (24h):
Reddit: [--]
X: [-----]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ctmx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ctmx/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
1-Year High: [---] on 2025-11-12  
1-Year Low: [--] on 2025-04-22  

Mentions by network (24h):
Reddit: [--]
X: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ctmx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ctmx/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning $ctmx in the last [--] hours which is down 22% from [--] in the previous [--] hours
Daily Average: [--]  
1-Year High: [---] on 2025-05-14  
1-Year Low: [--] on 2025-04-22  

The most influential creators that mention $ctmx in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BOSSTRADING0](/creator/twitter/BOSSTRADING0)       | [--]    | [-----]     | [--]     | [---]         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [---]         |
| [@anexpertone](/creator/twitter/anexpertone)         | [--]    | [--]        | [--]     | [---]         |
| [@_Etere_](/creator/twitter/_Etere_)                 | [--]    | [--]        | [--]     | [---]         |
| [@seedy19tron](/creator/twitter/seedy19tron)         | [--]    | [------]    | [--]     | [--]          |
| [@Bionavgator](/creator/twitter/Bionavgator)         | [--]    | [---]       | [--]     | [--]          |
| [@mariostario2019](/creator/twitter/mariostario2019) | [--]    | [--]        | [--]     | [--]          |
| [@GuzmanAlic16045](/creator/twitter/GuzmanAlic16045) | [--]    | [--]        | [--]     | [--]           |

[View More](/list/creators/$ctmx/100)
  
  
### Sentiment: 80%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ctmx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ctmx/time-series/sentiment.tsv)  
Current Value: 80%  
Daily Average: 86%  
[--] Week: 100% +25%  
[--] Month: 100% +11%  
[--] Months: 100% +15%  
[--] Year: 100% no change  
1-Year High: 100% on 2025-02-18  
1-Year Low: 33% on 2025-12-03  

Most Supportive Themes:
- Varseta-M for CRC: (20%) CytomX is advancing Varseta-M, a potential first-in-class ADC, towards a registrational study in late-line Colorectal Cancer (CRC).
- CX-801 Melanoma Results: (10%) CytomX announced upcoming presentation of Phase [--] Melanoma results for CX-801.
  
Most Critical Themes:
- CX-2051 Phase [--] Update: (30%) All eyes are on the CX-2051 Phase [--] update in Q1, with potential concerns regarding small sample size efficacy numbers and a past patient death.
  

### Top $ctmx Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"We're going UPPP $IRTC $ACHL $PTGX $KRYS $TGTX $PRVB $RXRX $AMRN $IRWD $URGN $RPTX $SAGE $ARWR $VACC $TWST $FOLD $MRTX $VERA $MIRM $IOVA $ABS $PRDS $RAPT $ODT $CTMX $PTPI $FREQ $PMVP $BPMC $UBX $GRTS $FRLN $ELDN $QURE $IDRA $CGON $NKTR $RIGL $NRRSF $NOM Norsemont Mining Breakout Brewing 🚨 NRRSF is flashing a clean reversal setup after reclaiming long-term resistance and holding rising trendline support. 📊 Key Levels * Support: $0.75$0.80 * Pivot: $0.85$0.90 * Major Resistance: $1.00 * Targets: $1.20$1.40 https://t.co/W2T6nwpnkN $NRRSF $NOM Norsemont Mining Breakout Brewing 🚨 NRRSF is"  
[X Link](https://x.com/mariostario2019/status/2019798905823637939) [@mariostario2019](/creator/x/mariostario2019) 2026-02-06T15:42Z [--] followers, [---] engagements


"$CTMX FMR out with a new 13G/A showing 20% increase in shares. Now up to a whopping [--------] shares representing 14.9% in the company. https://fintel.io/so/us/ctmx/fmr-llc https://fintel.io/so/us/ctmx/fmr-llc"  
[X Link](https://x.com/rddbryant/status/2019478816389796238) [@rddbryant](/creator/x/rddbryant) 2026-02-05T18:30Z [--] followers, [---] engagements


"$CTMX CEO very very active drug in late line CRC is what sticks out to other researchers Cantor Catalysts: Webinar with $CTMX Tomorrow (February 3rd @ 2:30PM ET) Cantor Catalysts: Webinar with $CTMX Tomorrow (February 3rd @ 2:30PM ET)"  
[X Link](https://x.com/semodough/status/2018772183598682266) [@semodough](/creator/x/semodough) 2026-02-03T19:42Z 42.4K followers, 18.3K engagements


"2026 current portfolio: $ARVN $BHVN $CYTK $CTMX $GH $IDYA $IMVT $KURA $LNTH $RVMD $RIGL $TNGX $TYRA"  
[X Link](https://x.com/STL_Biotech/status/2016970897219871222) [@STL_Biotech](/creator/x/STL_Biotech) 2026-01-29T20:25Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing